Aspire Broking Pty. Ltd.

Status: Registered
Australian Company Number: 602073290
Australian Business Number: 35602073290
Registration date: 2014-09-29
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Aspire Broking Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3337 since 2014-09-29 the company is, as the updated on 2014-09-29 ABN database shows, registered. Known company numbers for Aspire Broking Pty Ltd are as follows: ACN - 602073290, Australian Business Number - 35602073290.


Details for ABN 35602073290

Type: Australian Private Company

ABN Status

Status From To
Active 2014-09-29 current

Main Name

Name From To
Aspire Broking Pty. Ltd. 2014-09-29 current

Main Location

Location From To
VIC 3337 2014-09-29 current


Financial Services Authorised Representative data

Licence number: 000226403

Register Name AFS Representative
AFS Representative Number 000469761
Appointment status Ceased
AFS authorised representative start date 2014-12-03
AFS authorised representative end date 2015-09-16
AFS Representative's principal business address Southbank
Can appoint other Australian Financial Services representatives No
Australian Financial Services authorisations:
AFS authorised representative will be assigned licence authorisations by the licensee No
last updated : 2016-05-29

Find company

VIC 3337 Location

2018 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (, and, ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.